KCP
JAZZ icon

Kera Capital Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Kera Capital Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$554K Buy
2,297
+132
+6% +$28.9K 0.05% 292
2026
Q1 		$409K Buy
2,165
+121
+6% +$21.1K 0.05% 309
2025
Q4 		$336K Buy
+2,044
New +$313K 0.04% 367
2025
Q2 		– Sell
-1,891
Closed -$235K – 360
2025
Q1 		$235K Sell
1,891
-445
-19% -$58.1K 0.07% 155
2024
Q4 		$288K Buy
+2,336
New +$275K 0.08% 83

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Kera Capital Partners's JAZZ Position: Q2 2026 in Review

Kera Capital Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 6.1% in Q2 2026, buying an estimated $28.9K and bringing the position to 2,297 shares worth $554K. The position accounts for 0.05% of the portfolio, ranked #292.

Kera Capital Partners first reported a position in JAZZ in Q4 2024 and has held it in 5 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Kera Capital Partners held 2,297 shares of Jazz Pharmaceuticals worth $554K as of Q2 2026.
  • Kera Capital Partners bought 132 Jazz Pharmaceuticals shares in Q2 2026, an estimated $28.9K.
  • Jazz Pharmaceuticals made up 0.05% of Kera Capital Partners's portfolio in Q2 2026, its #292 holding.
  • Kera Capital Partners first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.